CB
47
3
CMA
65
12
FITB
65
13
LYB
39
3
GME
59
2
KEY
53
19
BRK.B
42
15
AIG
38
3
PPG
60
4
HCA
48
-5
HIG
62
8
ITW
70
6
GIS
26
-3
LEN
48
-5
VZ
34
-3
HUM
48
11
ETN
80
11
VRSN
57
7
DGX
44
8
PM
50
-16
CB
47
3
CMA
65
12
FITB
65
13
LYB
39
3
GME
59
2
KEY
53
19
BRK.B
42
15
AIG
38
3
PPG
60
4
HCA
48
-5
HIG
62
8
ITW
70
6
GIS
26
-3
LEN
48
-5
VZ
34
-3
HUM
48
11
ETN
80
11
VRSN
57
7
DGX
44
8
PM
50
-16
Financhill
Back

Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
17

VRCA
Verrica Pharmaceuticals

Last Price:
0.72
Seasonality Move:
31.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Verrica Pharmaceuticals Price Quote

$0.72
-0.03 (-3.52%)
(Updated: November 7, 2024 at 12:45 PM ET)

Verrica Pharmaceuticals Key Stats

Sell
17
Verrica Pharmaceuticals (VRCA) is a Sell
Day range:
$0.74 - $0.87
52-week range:
$0.75 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.03
P/B ratio:
0%
Volume:
1.8M
Avg. volume:
1M
1-year change:
-80.26%
Market cap:
$34M
Revenue:
$5.1M
EPS:
$-1.84

How Much Does Verrica Pharmaceuticals Make?

Is Verrica Pharmaceuticals Growing As A Company?

Data Unavailable

Verrica Pharmaceuticals Stock Price Performance

What Is Verrica Pharmaceuticals 52-Week High & Low?

Verrica Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verrica Pharmaceuticals?

Is Verrica Pharmaceuticals Cash Flow Positive?

  • What Is VRCA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.4M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$254K

Verrica Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRCA return on invested capital is -184.44%
  • What Is Verrica Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -128.78%
  • What Is VRCA Return On Equity?
    ROE is a measure of profitability and is -2619.46%

Verrica Pharmaceuticals Earnings Date & Stock Price

Verrica Pharmaceuticals Competitors

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.45%
Revenue: 0% -133.85%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 9.50
Upside from Last Price: 1172.95%

Major Shareholders

  • How many VRCA shares are owned by institutional investors?
    26.7M VRCA shares are owned by institutional investors
  • How many VRCA shares are owned by insiders?
    11.7M VRCA shares are owned by insiders